Lack of relationship between the PlA1 /PlA2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction
- 1 May 1998
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 28 (5) , 385-388
- https://doi.org/10.1046/j.1365-2362.1998.00298.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosisThe Lancet, 1997
- Platelet Glycoprotein IIIaPlAPolymorphism and Myocardial InfarctionNew England Journal of Medicine, 1996
- Platelet Membrane Receptor Glycoprotein IIb/IIIa Antagonism in Unstable AnginaCirculation, 1996
- A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary ThrombosisNew England Journal of Medicine, 1996
- Coronary Plaque DisruptionCirculation, 1995
- Genetic Susceptibility to Death from Coronary Heart Disease in a Study of TwinsNew England Journal of Medicine, 1994
- Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectorisThe Lancet, 1992
- Low-Dose Aspirin Therapy for Chronic Stable AnginaAnnals of Internal Medicine, 1991
- The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.Journal of Clinical Investigation, 1989
- Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.Circulation, 1979